Jasper Therapeutics, Inc.
JSPRNasdaqCIK 1788028HealthcareFiscal year ends Dec 31
Reports and events: 142 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-06-1208:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-051891 |
| 2024-05-1413:53 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-042805 |
| 2024-04-2213:13 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001213900-24-034820 |
| 2024-03-0516:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-020114 |
| 2024-03-0407:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-019249 |
| 2024-02-0920:36 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-24-000336 |
| 2024-02-0609:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-010267 |
| 2024-01-0406:04 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-000980 |
| 2024-01-0208:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-000056 |
| 2023-12-2006:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-097100 |
| 2023-11-2017:11 ET | DEF 14A | Proxy statementPeriod 2023-12-15 | 0001213900-23-088825 |
| 2023-11-0909:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-084970 |
| 2023-11-0908:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-084938 |
| 2023-11-0108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-081941 |
| 2023-10-2006:04 ET | 8-K | 3.01 Delisting notice | 0001013762-23-005230 |
| 2023-10-1007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-081286 |
| 2023-10-1006:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-081265 |
| 2023-09-2508:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-078927 |
| 2023-09-2108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-078145 |
| 2023-08-1116:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-066234 |
| 2023-08-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-066233 |
| 2023-06-2016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-050029 |
| 2023-06-0816:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-047446 |
| 2023-06-0217:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-045834 |
| 2023-05-1216:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-039021 |
| 2023-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-038997 |
| 2023-04-2116:01 ET | DEF 14A | Proxy statementPeriod 2023-06-07 | 0001213900-23-031673 |
| 2023-04-1416:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-23-029872 |
| 2023-03-0816:10 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-018542 |
| 2023-03-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-018537 |
| 2023-02-2716:05 ET | SC 13D | Ownership report, active investor | 0000921895-23-000611 |
| 2023-02-1708:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-012596 |
| 2023-02-1616:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-012446 |
| 2023-01-2713:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-005582 |
| 2023-01-2516:44 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-005155 |
| 2023-01-2416:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-004843 |
| 2023-01-1908:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-003597 |
| 2023-01-1308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-002591 |
| 2023-01-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-001835 |
| 2022-11-1017:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-071292 |
| 2022-11-1016:09 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-071165 |
| 2022-11-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-071153 |
| 2022-11-0416:01 ET | 8-K | 3.01 Delisting notice | 0001213900-22-069368 |
| 2022-08-1216:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-047382 |
| 2022-08-1216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-047374 |
| 2022-06-2716:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-22-035178 |
| 2022-05-1216:10 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-025945 |
| 2022-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-025933 |
| 2022-04-2916:01 ET | DEF 14A | Proxy statementPeriod 2022-06-23 | 0001213900-22-022704 |
| 2022-04-2716:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-021894 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 08:12 ET. Listed shows no prices and gives no investment advice.